Oxford Asset Management »

C4 Therapeutics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $138k 86k 1.60

More positions owned by Oxford Asset Management

Spdr Series Trust S&p Biotech (XBI)
Snap Note 0.125% 3/0
Freeport-mcmoran CL B (FCX)
Dropbox Note 3/0
General Mills (GIS)
Ford Motor Company (F)
Comcast Corp Cl A (CMCSA)
Citigroup Com New (C)
Ferguson Enterprises Common Stock New (FERG)
Nike CL B (NKE)
Amazon (AMZN)
Boeing Company (BA)
EOG Resources (EOG)
Pfizer (PFE)
Meridianlink Common Stock (MLNK)

View all positions for Oxford Asset Management

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Soleus Capital Management
OrbiMed Advisors
Daniel D. Thurber
Vanguard Group
Millennium Management
Silverarc Capital Management
BlackRock
Bain Capital Life Sciences Investors
Renaissance Technologies
Tang Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management
Susquehanna International

View all funds holding C4 Therapeutics